文献速递血液净化与透析

计划性血液透析较腹膜透析具有生存优势:一项队列研究

Survival advantage of planned haemodialysis over peritoneal dialysis: a cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究基于法国 REIN 登记系统 2006–2008 年 13 767 例起始透析的成人患者,比较计划性血液透析(HD)与腹膜透析(PD)的生存差异。采用倾向评分 Cox 模型、边际结构模型等方法校正混杂后,HD 组生存率 consistently 优于 PD 组,但边际结构模型显示两组生存差距趋于缩小。

要点

  • 计划性 HD 起始患者中位生存 53.5 个月,PD 为 38.6 个月。
  • 多模型校正后 HD 死亡风险均低于 PD(HR 0.67–0.82)。
  • 边际结构模型显示 PD 与 HD 生存差距较传统模型缩小。

核心结论

  • 该大型队列研究采用多种统计方法减少偏倚,显示计划性 HD 较 PD 生存更优。

研究设计与样本

  • 基于法国 REIN 登记系统的全国性队列研究,纳入 2006–2008 年起始肾脏替代治疗的成人患者 13 767 例。
  • 排除紧急起始透析或 2 个月内停止肾脏替代治疗者。
  • 采用倾向评分 Cox 模型、边际结构模型等校正缺乏随机化及时间依赖治疗与混杂因素。

主要发现

  • 起始透析时 13% 为 PD,87% 为 HD。
  • HD 组中位生存 53.5 个月(4.45 年),PD 组 38.6 个月(3.21 年)。
  • 倾向评分 Cox 模型 HR 0.76(95%CI 0.69–0.84),每次治疗变更设删失的 Cox 模型 HR 0.67(95%CI 0.62–0.73),边际结构模型 HR 0.82(95%CI 0.69–0.97),均支持 HD 生存优势。
  • 边际结构模型倾向于缩小 PD 与 HD 患者间的生存差距。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies comparing the outcomes in haemodialysis (HD) with those in peritoneal dialysis (PD) have yielded conflicting results. METHODS: The aim of the study was to compare the survival of planned HD versus PD patients in a cohort of adult incident patients who started renal replacement therapy (RRT) between 2006 and 2008 in the nationwide REIN registry (Réseau Epidémiologie et Information en Néphrologie). Patients who started RRT in emergency or stopped RRT within 2 months were excluded. Adjusted Cox models, propensity score matching and marginal structural models (MSMs) were used to compensate for the lack of randomization and provide causal inference from longitudinal data with time-dependent treatments and confounders including transplant censorship, modality change over time and time-varying covariates. RESULTS: Among a total of 13 767 dialysis patients, 13% were on PD at initiation of RRT and 87% were on HD. The median survival times were 53.5 months or 4.45 years and 38.6 months or 3.21 years for patients starting on HD and PD, respectively. Regardless of the model used, there was a consistent advantage in terms of survival for HD patients: hazard ratio (HR) 0.76 [95% confidence interval (95% CI) 0.69-0.84] with the Cox model using propensity score; HR 0.67 (95% CI 0.62-0.73) in the Cox model with censorship for each treatment change; and HR 0.82 (95% CI 0.69-0.97) with MSMs. However, MSMs tended to reduce the survival gap between PD and HD patients. CONCLUSION: This large cohort study using various statistical methods to minimize the bias appears to demonstrate a better survival in planned HD than in PD.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Thiery A, Séverac F, Hannedouche T, et al. Survival advantage of planned haemodialysis over peritoneal dialysis: a cohort study. Nephrol Dial Transplant. 2018. PMID: 29447408. doi:10.1093/ndt/gfy007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。